Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05600283 · ClinicalTrials.gov registry record · NA
Patient Self-sampling of HPV to Screen for Cervical Cancer
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 222
- Enrollment target
NCT05600283: Completed NA study, sponsored by Mayo Clinic.
NCT05600283 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 222 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05600283, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
Study Summary
The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.
Primary Outcome
Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection
Interventions
- DIAGNOSTIC_TEST Swab kit (COBAS HPV 4800 Assay -Evalyn brush)
- DIAGNOSTIC_TEST Clinician-collection of cervical sample for HPV testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2024-06-04 |
| Phase | NA |
What the finished NCT05600283 record still lists
NCT05600283 is an interventional study that assigns participants to a tested intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which Swab kit (COBAS HPV 4800 Assay -Evalyn brush) is the first listed.
NCT05600283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05600283 about?
NCT05600283 is a clinical study titled "Patient Self-sampling of HPV to Screen for Cervical Cancer". The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cerv...
What is the current status of trial NCT05600283?
This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2022-11-16. Estimated completion is 2024-06-04.
What interventions are being tested in trial NCT05600283?
The interventions under investigation include: Swab kit (COBAS HPV 4800 Assay -Evalyn brush) (DIAGNOSTIC_TEST), Clinician-collection of cervical sample for HPV testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05600283?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05600283's enrollment target sits among peer trials
222 481st of 2000 higher than 1,520 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI